Susquehanna International Group, LLP Sarepta Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $48.7 Million - $61.4 Million	-391,800 Reduced 54.36%	329,000 $41.1 Million
Q2 2024 Aug 15, 2024	BUY	$113.33 - $163.85 $43.6 Million - $63.1 Million	384,900 Added 114.59%	720,800 $114 Million
Q1 2024 May 07, 2024	SELL	$93.7 - $141.53 $38.8 Million - $58.6 Million	-413,900 Reduced 55.2%	335,900 $43.5 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $1.43 Million - $2.66 Million	-21,300 Reduced 2.76%	749,800 $72.3 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $36.7 Million - $44.3 Million	-358,300 Reduced 31.72%	771,100 $93.5 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $46.6 Million - $68.8 Million	437,800 Added 63.3%	1,129,400 $129 Million
Q1 2023 May 16, 2023	BUY	$117.53 - $155.99 $58.2 Million - $77.2 Million	494,800 Added 251.42%	691,600 $95.3 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $11.3 Million - $14.8 Million	112,200 Added 132.62%	196,800 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $1.76 Million - $2.78 Million	23,300 Added 38.01%	84,600 $9.35 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.5B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.